← Back to Search

Procedure

catheter ablation using magnetic navigation for Ventricular Tachycardia (MAGNETIC-VT Trial)

N/A
Waitlist Available
Led By Andrea Natale, MD
Research Sponsored by Stereotaxis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Summary

The study purpose is to demonstrate that ventricular tachycardia (VT) ablation using the Niobe™ ES system results in superior outcomes compared to a manual approach in subjects with ischemic scar VT in a low ejection fraction population.

Eligible Conditions
  • Ventricular Tachycardia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
acute success of procedure
major adverse events
Other study objectives
Patient quality of life (SF-12)
Total ablation energy delivery

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Magnetic navigationExperimental Treatment1 Intervention
Catheter ablation using magnetic navigation for ventricular tachycardia via remote magnetic navigation of a NaviStar RMT ThermoCool catheter, or other magnetically compatible catheter, via Stereotaxis's Niobe ES system.
Group II: Manual navigationActive Control1 Intervention
Catheter ablation using manual navigation for ventricular tachycardia via a manually navigated Thermocool catheter, or equivalent catheter.

Find a Location

Who is running the clinical trial?

StereotaxisLead Sponsor
11 Previous Clinical Trials
685 Total Patients Enrolled
Andrea Natale, MDPrincipal InvestigatorTexas Cardiac Arrhythmia Research Foundation
35 Previous Clinical Trials
8,036 Total Patients Enrolled
~19 spots leftby Sep 2025